Acute and long-term effects of resistance-training regimens with varied combinations of high- and low-intensity exercises were studied. Acute changes in the serum growth hormone (GH) concentration were initially measured after 3 types of regimens for knee extension exercise: a medium intensity (approximately 10 repetition maximum [RM]) short interset rest period (30 s) with progressively decreasing load ("hypertrophy type"); 5 sets of a high-intensity (90% of 1RM) and low-repetition exercise ("strength type"); and a single set of low-intensity and high-repetition exercise added immediately after the strength-type regimen ("combi-type"). Postexercise increases in serum GH concentration showed a significant regimen dependence: hypertrophy-type > combi-type > strength-type (p < 0.05, n = 8). Next, the long-term effects of periodized training protocols with the above regimens on muscular function were investigated. Male subjects (n = 16) were assigned to either hypertrophy/combi (HC) or hypertrophy/ strength (HS) groups and performed leg press and extension exercises twice a week for 10 weeks. During the first 6 weeks, both groups used the hypertrophy-type regimen to gain muscular size. During the subsequent 4 weeks, HC and HS groups performed combi-type and strength-type regimens, respectively. Muscular strength, endurance, and cross sectional area (CSA) were examined after 2, 6, and 10 weeks. After the initial 6 weeks, no significant difference was seen in the percentage changes of all variables between the groups. After the subsequent 4 weeks, however, 1RM of leg press, maximal isokinetic strength, and muscular endurance of leg extension showed significantly (p < 0.05) larger increases in the HC group than in the HS group. In addition, increases in CSA after this period also tended to be larger in the HC group than in the HS group (p = 0.08). The results suggest that a combination of high- and low-intensity regimens is effective for optimizing the strength adaptation of muscle in a periodized training program.
To investigate the effects of cooling on local temperature and circulation in the skin and skeletal muscle at different cooling temperatures. Ten male subjects (mean age 24.9 years) participated in this study. Intramuscular temperatures were measured by inserting two 22-gauge temperature probes (needle length; 8 and 18 mm) into the ankle dorsiflexors, while skin temperature was measured using a thermocouple attached to the leg skin anteriorly. Near-infrared spectroscopy was also used to evaluate the concentration changes in oxygenated, deoxygenated, and total hemoglobin/myoglobin in local skin and skeletal muscle. These measurements were simultaneously performed during the 10-min noncooling, 30-min cooling (cooling pad temperature; 0, 10, or 20 degrees C), and 60-min recovery periods. Under all cooling conditions, skin and intramuscular temperatures decreased during cooling (P < 0.01) and began to increase after the cooling pad was removed. However, these values did not return to baseline values during the recovery period (P < 0.01). Moreover, tissue temperatures tended to show lower values during cooling at lower cooling temperatures. All hemoglobin/myoglobin concentrations also showed a concomitant significant decrease during cooling under three cooling conditions (P < 0.01); the oxygenated and total hemoglobin/myoglobin concentrations did not return to the exact values before cooling during the recovery period. This study suggested that the rate of decrease in tissue temperature depends on the cooling temperature and the effects of cooling on tissue temperatures and circulation tend to be maintained during 60 min post-cooling period despite the cooling temperature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.